AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.

Also called NCT06123130

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 198 participants (enrolled count) (from the registry)
Sponsor
HeartBeam, Inc. (from the registry)
Registry
  • NCT NCT06123130
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06123130. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-03-13 (actual); primary completion 2024-06-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection
Acronym
VALID-ECG
Condition
Arrhythmias, Cardiac
Condition
Bradycardia
Condition
Tachycardia
Intervention (Device)
Vectorcardiography (VECG)
Lead sponsor
HeartBeam, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06123130
Content hash
14ddcc0de6cb18b41e57454c114f7286943276084ca066447c399319c95ba4dd